Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors

PLoS ONE - United States
doi 10.1371/journal.pone.0100178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Chondroitin Sulfate Proteoglycan (CSPG)

Science-Business eXchange
2014English

Chondroitin Sulfate Proteoglycan 4 Specific Chimeric Antigen Receptor Therapy for Pediatric Solid Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

NG2/CSPG4 Proteoglycan as a Novel Prognostic Indicator and Therapeutic Target in Malignant Cancer

Journal of Stem Cell Research & Therapy
2014English

Molecular Cloning of a Human Melanoma-Associated Chondroitin Sulfate Proteoglycan.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Neuroglycan C, a Novel Membrane-Spanning Chondroitin Sulfate Proteoglycan That Is Restricted to the Brain

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Chondroitin Sulfate Proteoglycan 4 and Its Potential as an Antibody Immunotherapy Target Across Different Tumor Types

Frontiers in Immunology
AllergyImmunology
2018English

Increased Synthesis of Chondroitin Sulfate Proteoglycan Promotes Adult Hippocampal Neurogenesis in Response to Enriched Environment

Journal of Neuroscience
Neuroscience
2018English

Targeted Downregulation of N-Acetylgalactosamine 4-Sulfate 6-O-Sulfotransferase Significantly Mitigates Chondroitin Sulfate Proteoglycan-Mediated Inhibition

GLIA
Molecular NeuroscienceNeurologyCellular
2011English

Histochemical Differentiation Between Chondroitin 4-Sulfate and Chondroitin 6-Sulfate.

Kurume Medical Journal
Medicine
1978English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy